COMPANY

ceo이미지

CEODr.Yosep Ji

View History

33

Publications

8

Award

18

Research Career

- 5th Young Scientist Award from International Scientific Conferences

- Head of the our research and service development for improving gut microbiota

- Around 20 publications in the field

cto이미지

CTODr. Wilhelm Heinrich Holzapfel

View History

360

Publications

8

Books

70

Book Chapters

100

Thesis Advisor for Graduates

- Around 45 years of experience in teaching and research in various fields of basic and applied microbiology

- Former Head (1987-2007) of the Federal Research Institute of Hygiene and Toxicology at the BFE, Karlsruhe, now Max Rubner Institut (MRI), Germany.

- Formerly (1996-2007): Honorary Professor at Karlsruhe Technical University (KIT: Karlsruhe Institute of Technology).

- Presently: Chair Professor at Handong Global University.

- Presently (since 1996): President of the ICFMH of the IUMS (International Committee on Food Microbiology and Hygiene of the International Union of Microbiological Societies).

- Presently (since 1986): Member of the IUMS Subcommittee on the Taxonomy of Bifidobacterium and Lactobacillus and related organisms.

  • 2021

    May

    Changed company name to HEM Pharma

    February

    Completion of GMP drug substance production facility

    January

    Amway Balance Within Immunity launch

  • 2020

    November

    Start clinical trial for depression efficacy evaluation

    September

    LARS efficacy evaluation clinical trial started

    ISO 9001 quality management system certification

    April

    Post-Synergy service launch

    March

    Gut Microbiome-Matabolome research service launch

    January

    Exclusive sales contract for Oh My Gut service with Access Business Group

  • 2019

    September

    Business agreement with Cosmax NBT for exchange of lactic acid bacteria research and product development and sales

    August

    Completion of aseptic mouse research facility in Pohang

  • 2018

    1 September

    Establishment of 'Han-dong SaM' joint venture with Pohang Handong Global University, Pohang

    8 June

    Recognized as an affiliated research institute

    1 April

    Establishment of HEM Gwanggyo Research Center in Suwon, South Korea.

  • 2017

    September

    LARS efficacy evaluation clinical trial started

    22 August

    MOU Signed with Lactomason and agreement on technology transfer

    21 May ~ NOW

    A $ 600,000 scale contract with Better Air(Israel) about transfer of effective microbial technology for environmental purification

    1 January

    Holzapfel Effective Microbes established

It is the center where researches and sales of technologies and services that are actively being commercialized are carried out.
There are research teams, data analysis teams and sales teams to make technology and services more sophisticated.

Address
404, Ace Gwanggyo Tower 3, 77, Changnyong-daero 256-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, S. Korea
Number
+82-1899-4258
Fax
+82-31-5186-6074
Email
hem@hempharma.bio

It is the center of research institutes that focus on the main research of HEM Pharma.
Collaborations with many research students are also being carried out in cooperation with Handong Global University.

Address
204, Business incubator center, Handong Global University, 558, Handong-ro, Heunghae-eup, Buk-gu, Pohang-si, Gyeongsangbuk-do, Republic of Korea 37554
Number
+82-54-260-3122
Fax
+82-54-700-0787
Email
hem@hempharma.bio
SERVICE
CENTER